Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

被引：38

作者：

Bas, M. ^{[1
]}

Bier, H. ^{[1
]}

Greve, J. ^{[1
]}

Kojda, G. ^{[1
]}

Hoffmann, T. K. ^{[1
]}

机构：

[1] Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany

来源：

ALLERGY | 2006年 / 61卷 / 12期

关键词：

angiotensin-converting enzyme inhibitor; angioedema; bradykinin B-2-receptor antagonist; C-1-esterase inhibitor deficiency; icatibant;

D O I：

10.1111/j.1398-9995.2006.01197.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1490 / 1492

页数：4

共 4 条

[1] HEREDITARY AND ACQUIRED C1-INHIBITOR DEFICIENCY - BIOLOGICAL AND CLINICAL CHARACTERISTICS IN 235 PATIENTS [J].

AGOSTONI, A ;

CICARDI, M .

MEDICINE, 1992, 71 (04) :206-215

[2] C1 inhibitor deficiency: consensus document [J].

Gompels, MM ;

Lock, RJ ;

Abinun, M ;

Bethune, CA ;

Davies, G ;

Grattan, C ;

Fay, AC ;

Longhurst, HJ ;

Morrison, L ;

Price, A ;

Price, M ;

Watters, D .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03) :379-394

[3]

ICATIBANT, 2005, DRUGS R D, V6, P239

[4] Plasma bradykinin in angio-oedema [J].

Nussberger, J ;

Cugno, M ;

Amstutz, C ;

Cicardi, M ;

Pellacani, A ;

Agostoni, A .

LANCET, 1998, 351 (9117) :1693-1697

← 1 →